Statin use and the risk of Clostridium difficile infection: a systematic review with meta-analysis
Raseen Tariq,1,2 Dhruvika Mukhija,3 Arjun Gupta,4 Siddharth Singh,5 Darrell S Pardi,1 Sahil Khanna1 1Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, 2Department of Internal Medicine, Rochester General Hospital, Rochester, NY, 3Department of Internal Medicine, Cleveland Clini...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2018-03-01
|
| Series: | Infection and Drug Resistance |
| Subjects: | |
| Online Access: | https://www.dovepress.com/statin-use-and-the-risk-of-clostridium-difficile-infection-a-systemati-peer-reviewed-article-IDR |
| _version_ | 1818201880069668864 |
|---|---|
| author | Tariq R Mukhija D Gupta A Singh S Pardi DS Khanna S |
| author_facet | Tariq R Mukhija D Gupta A Singh S Pardi DS Khanna S |
| author_sort | Tariq R |
| collection | DOAJ |
| description | Raseen Tariq,1,2 Dhruvika Mukhija,3 Arjun Gupta,4 Siddharth Singh,5 Darrell S Pardi,1 Sahil Khanna1 1Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, 2Department of Internal Medicine, Rochester General Hospital, Rochester, NY, 3Department of Internal Medicine, Cleveland Clinic, Cleveland, OH, 4Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, 5Division of Gastroenterology and Hepatology, University of California San Diego, La Jolla, CA, USA Purpose: Statins have pleiotropic effects beyond cholesterol lowering by immune modulation. The association of statins with primary Clostridium difficile infection (CDI) is unclear as studies have reported conflicting findings. We performed a systematic review and meta-analysis to evaluate the association between statin use and CDI.Patients and methods: We searched MEDLINE, Embase, and Web of Science from January 1978 to December 2016 for studies assessing the association between statin use and CDI. The Newcastle–Ottawa Scale was used to assess the methodologic quality of included studies. Weighted summary estimates were calculated using generalized inverse variance with random-effects model.Results: Eight studies (6 case–control and 2 cohort) were included in the meta-analysis, which comprised 156,722 patients exposed to statins and 356,185 controls, with 34,849 total cases of CDI available in 7 studies. The rate of CDI in patients with statin use was 4.3%, compared with 7.8% in patients without statin use. An overall meta-analysis of 8 studies using the random-effects model demonstrated that statins may be associated with a decreased risk of CDI (maximally adjusted odds ratio [OR], 0.80; 95% CI, 0.66–0.97; P=0.02). There was significant heterogeneity among the studies, with an I2 of 79%. No publication bias was seen. Meta-analysis of studies that adjusted for confounders revealed no protective effect of statins (adjusted OR, 0.84; 95% CI, 0.70–1.01; P=0.06, I2=75%). However, a meta-analysis of only full-text studies using the random-effects model demonstrated a decreased risk of CDI with the use of statins (OR 0.77; 95% CI, 0.61–0.99; P=0.04, I2=85%).Conclusion: Meta-analyses of existing studies suggest that patients prescribed a statin may be at decreased risk for CDI. The results must be interpreted with caution given the significant heterogeneity and lack of benefit on analysis of studies that adjusted for confounders. Keywords: Clostridium difficile infection, incidence, meta-analysis, statins |
| first_indexed | 2024-12-12T03:00:35Z |
| format | Article |
| id | doaj.art-beed467413374bf3990f5ef2537c0c65 |
| institution | Directory Open Access Journal |
| issn | 1178-6973 |
| language | English |
| last_indexed | 2024-12-12T03:00:35Z |
| publishDate | 2018-03-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Infection and Drug Resistance |
| spelling | doaj.art-beed467413374bf3990f5ef2537c0c652022-12-22T00:40:38ZengDove Medical PressInfection and Drug Resistance1178-69732018-03-01Volume 1140541637198Statin use and the risk of Clostridium difficile infection: a systematic review with meta-analysisTariq RMukhija DGupta ASingh SPardi DSKhanna SRaseen Tariq,1,2 Dhruvika Mukhija,3 Arjun Gupta,4 Siddharth Singh,5 Darrell S Pardi,1 Sahil Khanna1 1Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, 2Department of Internal Medicine, Rochester General Hospital, Rochester, NY, 3Department of Internal Medicine, Cleveland Clinic, Cleveland, OH, 4Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, 5Division of Gastroenterology and Hepatology, University of California San Diego, La Jolla, CA, USA Purpose: Statins have pleiotropic effects beyond cholesterol lowering by immune modulation. The association of statins with primary Clostridium difficile infection (CDI) is unclear as studies have reported conflicting findings. We performed a systematic review and meta-analysis to evaluate the association between statin use and CDI.Patients and methods: We searched MEDLINE, Embase, and Web of Science from January 1978 to December 2016 for studies assessing the association between statin use and CDI. The Newcastle–Ottawa Scale was used to assess the methodologic quality of included studies. Weighted summary estimates were calculated using generalized inverse variance with random-effects model.Results: Eight studies (6 case–control and 2 cohort) were included in the meta-analysis, which comprised 156,722 patients exposed to statins and 356,185 controls, with 34,849 total cases of CDI available in 7 studies. The rate of CDI in patients with statin use was 4.3%, compared with 7.8% in patients without statin use. An overall meta-analysis of 8 studies using the random-effects model demonstrated that statins may be associated with a decreased risk of CDI (maximally adjusted odds ratio [OR], 0.80; 95% CI, 0.66–0.97; P=0.02). There was significant heterogeneity among the studies, with an I2 of 79%. No publication bias was seen. Meta-analysis of studies that adjusted for confounders revealed no protective effect of statins (adjusted OR, 0.84; 95% CI, 0.70–1.01; P=0.06, I2=75%). However, a meta-analysis of only full-text studies using the random-effects model demonstrated a decreased risk of CDI with the use of statins (OR 0.77; 95% CI, 0.61–0.99; P=0.04, I2=85%).Conclusion: Meta-analyses of existing studies suggest that patients prescribed a statin may be at decreased risk for CDI. The results must be interpreted with caution given the significant heterogeneity and lack of benefit on analysis of studies that adjusted for confounders. Keywords: Clostridium difficile infection, incidence, meta-analysis, statinshttps://www.dovepress.com/statin-use-and-the-risk-of-clostridium-difficile-infection-a-systemati-peer-reviewed-article-IDRClostridium difficile infectionincidencemeta-analysisstatins |
| spellingShingle | Tariq R Mukhija D Gupta A Singh S Pardi DS Khanna S Statin use and the risk of Clostridium difficile infection: a systematic review with meta-analysis Infection and Drug Resistance Clostridium difficile infection incidence meta-analysis statins |
| title | Statin use and the risk of Clostridium difficile infection: a systematic review with meta-analysis |
| title_full | Statin use and the risk of Clostridium difficile infection: a systematic review with meta-analysis |
| title_fullStr | Statin use and the risk of Clostridium difficile infection: a systematic review with meta-analysis |
| title_full_unstemmed | Statin use and the risk of Clostridium difficile infection: a systematic review with meta-analysis |
| title_short | Statin use and the risk of Clostridium difficile infection: a systematic review with meta-analysis |
| title_sort | statin use and the risk of clostridium difficile infection a systematic review with meta analysis |
| topic | Clostridium difficile infection incidence meta-analysis statins |
| url | https://www.dovepress.com/statin-use-and-the-risk-of-clostridium-difficile-infection-a-systemati-peer-reviewed-article-IDR |
| work_keys_str_mv | AT tariqr statinuseandtheriskofclostridiumdifficileinfectionasystematicreviewwithmetaanalysis AT mukhijad statinuseandtheriskofclostridiumdifficileinfectionasystematicreviewwithmetaanalysis AT guptaa statinuseandtheriskofclostridiumdifficileinfectionasystematicreviewwithmetaanalysis AT singhs statinuseandtheriskofclostridiumdifficileinfectionasystematicreviewwithmetaanalysis AT pardids statinuseandtheriskofclostridiumdifficileinfectionasystematicreviewwithmetaanalysis AT khannas statinuseandtheriskofclostridiumdifficileinfectionasystematicreviewwithmetaanalysis |